Medivir AB Series B | Income Statement
Fiscal year is January-December. All values SEK Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
446
1,767
474
93
37
24
Cost of Goods Sold (COGS) incl. D&A
72
207
38
16
400
363
Gross Income
374
1,560
436
77
364
339
SG&A Expense
342
379
384
338
-
-
EBIT
29
1,181
-
261
364
339
Unusual Expense
10
9
-
53
4
15
Non Operating Income/Expense
7
4
3
6
8
3
Interest Expense
-
2
2
9
-
-
Pretax Income
28
1,193
46
308
360
350
Income Tax
-
12
60
14
12
-
Equity in Affiliates
-
-
-
1
-
-
Consolidated Net Income
16
1,133
32
295
360
350
Net Income
16
1,133
32
295
360
350
Net Income After Extraordinaries
53
1,133
12
873
360
350
Net Income Available to Common
25
1,133
75
252
360
350
EPS (Basic)
0.68
36.24
2.59
10.50
16.40
14.62
Basic Shares Outstanding
31
31
29
27
22
24
EPS (Diluted)
0.68
35.90
2.56
10.50
16.40
14.62
Diluted Shares Outstanding
31
32
29
27
22
24
EBITDA
62
1,214
92
228
352
329
Other Operating Expense
4
-
-
-
-
-
Non-Operating Interest Income
4
-
-
-
-
-
About Medivir AB
View Profile
